CTOs on the Move

Grand Rapids Clinical Oncology Program

www.grcop.org

 
Grand Rapids Clinical Oncology Program is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.grcop.org
  • 75 Sheldon Blvd SE Ste 101
    Grand Rapids, MI USA 49503
  • Phone: 616.391.1230

Executives

Name Title Contact Details

Similar Companies

Ascendian Healthcare Consulting

Ascendian Healthcare Consulting is a Roseville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

E.I. Medical

E.I. Medical is a Loveland, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Card System (MCS)

Medical Card System, Inc. (MCS) is a San Juan, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St Lukes House Inc

St Lukes House Inc is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.